Yew Bio-Pharm Group Inc (YEWB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Sales | 27,308 | 27,884 | 37,597 | 40,540 | 51,348 |
| Cost of Goods | 23,781 | 27,110 | 26,873 | 35,478 | 48,114 |
| Gross Profit | 3,527 | 774 | 10,724 | 5,062 | 3,235 |
| Operating Expenses | 1,739 | -128 | 10,878 | 2,215 | 1,227 |
| Operating Income | 2,569 | 1,012 | 719 | 3,325 | 2,121 |
| Other Income | -1,075 | -15 | -548 | -111 | -97 |
| Pre-tax Income | 1,494 | 997 | 171 | 3,214 | 2,025 |
| Income Tax | 29 | 11 | 1,493 | 1 | 18 |
| Net Income Continuous | 1,465 | 986 | -1,322 | 3,213 | 2,007 |
| Net Income | $1,465 | $986 | $-1,322 | $3,213 | $2,007 |
| EPS Basic Total Ops | 0.03 | 0.02 | -0.03 | 0.06 | 0.04 |
| EPS Basic Continuous Ops | 0.03 | 0.02 | -0.03 | 0.06 | 0.04 |
| EPS Diluted Total Ops | 0.03 | 0.02 | -0.03 | 0.06 | 0.04 |
| EPS Diluted Continuous Ops | 0.03 | 0.02 | -0.03 | 0.06 | 0.04 |
| EPS Diluted Before Non-Recurring Items | N/A | N/A | -0.03 | 0.06 | 0.04 |
| EBITDA(a) | $5,386 | $2,839 | $1,474 | $7,071 | $11,053 |